Skip to main content

Proqr Therapeutics(PRQR-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Proqr Therapeutics

ZERNIKEDREEF 9
LEIDEN P7 2333 CK NLD
P: 31-88-166-7000
http://www.proqr.com

Sectors & Indices

Sector
Industry
Employees

Profile

ProQR Therapeutics B.V. is a biotech company. It is engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis (CF). The Company's lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. ProQR Therapeutics B.V. is headquartered in Leiden, the Netherlands.

Key Executives

NameTitle
Rene BeukemaDirector/General Counsel/Other Executive Officer
Daniel de BoerCEO/Co-Founder/Director
Gerard PlatenburgChief Scientific Officer/Co-Founder/Director
Sheila SponseleeCOO/Other Executive Officer
Jurriaan DekkersCFO

More from The Globe

Bullish on FirstEnergy Corp.
Monica Rizk
The most oversold and overbought stocks on the TSX
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
Monday’s analyst upgrades and downgrades
A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
opinion
Why are Canadian bank valuations so low?
Tom Bradley
number cruncher
Eleven U.S. semiconductor stocks showing strength
For Number Cruncher column in Globe Investor/ROB only.
Wednesday’s analyst upgrades and downgrades
An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
Bullish on Archer-Daniels-Midland Co.
Monica Rizk
Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.